Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Kraig Biocraft Laboratories (KBLB) Short term Debt (2018 - 2022)

Kraig Biocraft Laboratories (KBLB) has disclosed Short term Debt for 7 consecutive years, with $65292.0 as the latest value for Q3 2022.

  • Quarterly Short term Debt rose 8.82% to $65292.0 in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $65292.0 through Sep 2022, up 8.82% year-over-year, with the annual reading at $60000.0 for FY2021, N/A changed from the prior year.
  • Short term Debt hit $65292.0 in Q3 2022 for Kraig Biocraft Laboratories, roughly flat from $65292.0 in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $3.3 million in Q4 2018 to a low of $34000.0 in Q1 2019.
  • Historically, Short term Debt has averaged $356585.5 across 4 years, with a median of $60000.0 in 2021.
  • Biggest YoY gain for Short term Debt was 21.04% in 2022; the steepest drop was 8.82% in 2022.
  • Year by year, Short term Debt stood at $3.3 million in 2018, then tumbled by 98.35% to $55200.0 in 2019, then grew by 8.7% to $60000.0 in 2021, then grew by 8.82% to $65292.0 in 2022.
  • Business Quant data shows Short term Debt for KBLB at $65292.0 in Q3 2022, $65292.0 in Q2 2022, and $72622.0 in Q1 2022.